16/11/2000

MediVision group receives $2.5 million in purchase commitments

New Digital Imaging Products Released At AAO Well Received By Professional Community

Yokneam Elit, Israel , November 16, 2000. MediVision Medical Imaging Ltd. (EURO.NM: MEDV) announced that Ophthalmic Imaging Systems ("OIS") (OTCBB:OISI), of the MediVision group, received $2.5 million in purchase orders for its ophthalmic digital imaging systems during the 2000 Fall Meeting of the American Academy of Ophthalmology in Dallas, Texas, United States.

MediVision's President Noam Allon was very pleased with the magnitude of orders received and cited new OIS products which led to a considerable increase in orders received by the company in comparison with the previous year. "We believe that the significant orders received reflect our recent efforts in developing the highest resolution systems currently available and solidifying our position as the market leader in ophthalmic digital imaging,", said Noam Allon.

OIS unveiled two new digital imaging systems at the recent meeting. These products, the WinStation 1400 and WinStation 3000, both offer significantly higher resolution than the company's existing line of digital imaging products.

Jonathan Adereth, Chairman of the Board of Directors of OIS (and a MediVision Director), added, "We are very encouraged with the market's positive overall reaction to OIS at this first major trade meeting following our alliance with MediVision Medical Imaging Ltd., and in particular the favorable market acceptance of our new products. The addition of these products now enable us to address the needs of a wider spectrum of eye care professionals utilizing ophthalmic digital imaging systems."

MediVision, an Israeli company, designs, develops, manufactures and markets digital imaging devices for ophthalmic applications with an emphasis on diagnostics related to the Retina. MediVision's array of systems and their interconnectivity, allows the company to apply the "Complete Ophthalmic Digital Department" concept and also enables full connectivity between geographically distant clinics or hospitals and physicians.

OIS, a majority owned subsidiary of MediVision Medical Imaging Ltd., is a leading provider of ophthalmic digital imaging systems. OIS designs, develops, manufactures and markets digital imaging and image enhancement systems and analysis software. With over a decade in the ophthalmic imaging business, OIS has consistently been the first to introduce new technologies and features. OIS offers customer support through a worldwide network of service organization.

MediVision also announces that on October 30, 2000 it consummated a private placement of 60,336 of its shares at a per-share price of 3.09EUR (reflecting the average market price of the company's shares during the 30 day period immediately preceding the effective date of the placement agreement), to a Dutch investment group. These shares are subject to a gradually decreasing lock-up arrangement during a period of 8 months.

NOTE: THIS PRESS RELEASE CONTAINS FORWARD LOOKING STATEMENTS THAT ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE SET FORTH IN THE FORWARD LOOKING STATEMENTS. THESE FORWARD LOOKING STATEMENTS REPRESENT OPHTHALMIC IMAGING SYSTEMS' JUDGMENT AS OF THE DATE OF THIS RELEASE. OIS DISCLAIMS ANY INTENT OR OBLIGATION TO UPDATE THESE FORWARD-LOOKING STATEMENTS.